GONELLA JACQUES 4
4 · ANTARES PHARMA, INC. · Filed May 24, 2018
Insider Transaction Report
Form 4
GONELLA JACQUES
Director10% Owner
Transactions
- Sale
Common Stock
2018-05-23$2.53/sh−94,682$239,545→ 11,065,351 total - Sale
Common Stock
2018-05-23$2.50/sh−100,000$250,000→ 10,965,351 total - Sale
Common Stock
2018-05-22$2.53/sh−5,318$13,455→ 11,160,033 total
Footnotes (1)
- [F1]The sale of common stock reported in this Form 4 was made for estate planning purposes.